Biotechnology | Cardiology | Disease | Therapeutics | WHO
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
On Dec. 1, 2025, the World Health Organization (WHO) has released its first guideline on the use of…
Anonymous donor gifts $50M to help University of Washington train ‘unsung heroes’ of healthcare
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
Biotechnology | Infectious Disease | Measles | Vaccine | WHO
WHO Reports Measles deaths down 88% since 2000, but cases surge
On Nov. 28, 2025, the the World Health Organization (WHO) reported that global immunization efforts have led to…
China bans pork imports from Barcelona after Spain’s swine fever outbreak
On Nov. 28, 2025, China has banned pork imports from Barcelona province after Spain detected its first case…
Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer
On Nov. 24, 2025, a new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy…
Doctors still outperform AI in clinical reasoning, study shows
On Nov. 24, 2025, a study published in the New England Journal of Medicine show that a test…
CDC | Clinical Research | HIV | Infectious Disease | Medicine | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Veterinary
U.S. Centers for Disease Control and Prevention to End Monkey Research Program
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
WHO Reports Diphtheria outbreak in African Region
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
Biotechnology | CDC | Genomics | Infectious Disease | Influenza | Measles | Neurology | Vaccine
The West Coast Health Alliance Stands with Scientific Evidence: Vaccines Are Not Linked to Autism
On Nov. 21, 2025, state health officials from California, Oregon, Hawaii and Washington issued a statement in response…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Medical Device | Nanotechnology
new antibody test only takes 10 minutes, no blood draw necessary
On Nov. 20, 2025, an interdisciplinary research team at the University of Pittsburgh has developed wearable biosensors that…
Biotechnology | FDA | Oncology | Therapeutics
FDA approves first cancer drug based on Broad Institute science
On Nov. 20, 2025, the US Food and Drug Administration (FDA) has approved the first cancer drug based…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
CPRIT approves $154 million in new cancer research and prevention awards, surpasses $4 billion total
On Nov. 19, 2025, the governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
Neurolgic Form of Equine Herpes Virus Confirmed Following Texas Event
On Nov. 19, 2025, the Texas Animal Health Commission (TAHC) received confirmation of equine herpes myeloencephalopathy (EHM), the…
Novartis announces plans to build flagship manufacturing hub in North Carolina
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
CSL injects $2.3b into US for valuable blood plasma
On Nov. 18, 2025, CSL, Australia’s largest biotech company announced plans to expand its US presence with a…
Arrowhead Pharma Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplant
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
Utah, South Carolina confirm more measles as CDC call suggests U.S. elimination status in jeopardy
On Nov. 18, 2025, state officials in Utah report 84 measles cases in the state in a weekly…
Johnson & Johnson to acquire Halda Therapeutics for $3.05 billion, revolutionize treatment of cancer
On Nov. 17, 2025, Johnson & Johnson announced that it has entered into a definitive agreement to acquire…
Biotechnology | Disease | FDA | Therapeutics
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
On Nov. 17, 2025,In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have…
Agriculture | Artificial Intelligence | Biotechnology | Chemistry | Clinical Research | Diagnostics | Energy | Environmental | Infectious Disease | Marine Science | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine | Women's Health
NIH funding cuts have impacted more than 74,000 people enrolled in trials
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
First detection of H5N5 Avian influenza in a Human confirmed in Washington State resident
On Nov. 14, 2025, the Washington State Department of Health reported that a Grays Harbor resident who was…
Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family
On Nov. 14, 2025, A federal bankruptcy court judge said he will approve OxyContin-maker Purdue Pharma’s latest deal…
Merck to Acquire Cidara Therapeutics for $9.2 Billion, Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
Ethiopia reports suspected viral haemorrhagic fever outbreak
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
On Nov. 13, 2025, Legend Biotech announced the official opening and ribbon cutting of its new, state-of-the-art research…
New Jersey man’s death first one to be tied to tick-related meat allergy
On Nov. 13, 2025, a previously healthy New Jersey man has been identified by an allergist at the…